| PF-562271 |
ENSG00000088970.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000100181.17 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000124915.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000125804.9 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000126005.11 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000132832.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000145063.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000167117.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000168367.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000170161.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000170161.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000170161.6 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000171889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000171889.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000172250.10 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000172965.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000175061.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000175772.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000176728.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000177406.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000177738.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000177757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000178193.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000178412.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000178947.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000179141.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000179406.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000179818.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000179859.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000180769.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000181097.5 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000182165.13 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000182366.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000183674.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000184324.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000185044.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000185203.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000186056.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000189196.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000189223.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000189223.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000196421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000197085.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000197251.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000197462.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000197463.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000197670.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000197813.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000203280.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000203362.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000203364.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000203496.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000203497.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000203605.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000203650.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000203650.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000203801.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000203875.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000204044.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000204241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000204362.5 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000204528.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000204588.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000204706.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000204791.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000204792.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000204802.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000204832.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000204837.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000204929.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000205054.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000205628.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000205628.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000205634.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000205662.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000205913.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000206142.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000206176.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000212978.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000213468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000213742.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000213742.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000214105.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000214145.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000214184.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000214184.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000214347.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000214353.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000214407.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000214407.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000214691.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000214725.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000214894.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000214955.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000215256.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000215256.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000215394.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000215458.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000215808.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000216863.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000220161.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000221571.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000221817.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000222043.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000223356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000223380.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000223387.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000223392.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000223401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000223442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000223462.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000223478.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000223485.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000223525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000223571.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000223635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000223652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000223660.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000223695.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000223714.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000223734.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000223734.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000223745.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000223749.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000223764.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000223779.4 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000223784.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000223791.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000223797.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000223804.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000223842.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000223855.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000223935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000224020.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000224023.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000224032.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000224050.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000224078.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000224271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000224271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000224271.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000224292.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224468.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000224505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224577.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000224621.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000224623.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000224635.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000224638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000224638.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000224660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000224687.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224812.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000224843.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000224846.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000224885.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000224897.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000224939.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000224945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000224945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000224961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000224972.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000224992.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000225030.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225096.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000225113.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000225163.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000225173.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000225205.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000225213.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000225218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225265.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000225292.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225331.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000225353.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225439.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000225465.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000225527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000225541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000225548.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225579.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225595.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000225656.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000225675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000225762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225778.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000225790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000225836.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225839.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225914.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000225914.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000225945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000225963.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000225964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000225969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000225981.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000225981.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000225986.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000226009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000226029.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226149.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000226155.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000226179.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000226272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000226312.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000226328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000226332.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000226352.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000226352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000226377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000226386.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000226416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000226453.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000226455.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000226465.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000226465.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000226472.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226637.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000226645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000226645.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000226649.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000226754.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000226786.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000226851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000226856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000226862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000226877.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000226969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000227014.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227053.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227060.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000227071.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000227083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000227091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000227128.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227155.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000227161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000227172.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227388.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000227403.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000227479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227492.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227502.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227502.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227502.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227533.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000227540.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000227574.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000227617.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000227627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000227630.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000227674.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000227740.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000227741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000227773.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227811.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000227888.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000227906.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000227906.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000227908.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000227911.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000227953.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000227953.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000227959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000228010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228021.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000228033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000228043.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228063.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000228192.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000228201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000228204.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000228221.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000228237.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228274.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000228322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000228323.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228340.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000228389.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228389.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228412.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000228436.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000228437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000228506.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228549.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000228554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000228554.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000228554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228677.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228686.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000228686.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000228686.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000228719.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000228742.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000228763.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228775.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000228791.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000228801.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000228839.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228863.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000228886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000228886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000228889.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000228889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000228988.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000229056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229065.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000229105.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000229124.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000229191.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000229356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000229368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000229373.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000229382.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000229401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000229404.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000229521.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229587.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000229591.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000229642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000229728.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000229739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000229776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000229776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000229780.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000229839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000229848.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000229869.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000229915.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000229951.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000229970.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000230010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000230068.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000230068.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000230084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230084.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000230107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000230138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230212.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000230310.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000230333.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000230337.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000230394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000230427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000230438.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000230534.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000230542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000230565.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000230615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000230649.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000230658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000230679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000230679.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000230684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230695.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000230789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230790.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230880.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000230881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000230899.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000230914.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000230939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231010.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000231028.4 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000231057.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231073.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000231104.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231119.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000231154.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000231185.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000231226.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000231233.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231242.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231242.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231290.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231294.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000231355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000231401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000231441.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231447.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000231473.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231512.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000231521.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000231527.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000231551.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000231566.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000231574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000231595.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000231611.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000231611.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000231616.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231628.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000231636.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231636.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231638.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000231651.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000231652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231704.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000231705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000231711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000231713.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000231794.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000231806.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000231806.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000231840.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231908.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000231944.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000231999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000232018.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232043.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000232139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000232233.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000232233.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000232284.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000232295.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000232342.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000232363.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232363.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232411.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000232442.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000232470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000232470.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000232498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232504.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000232527.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000232527.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000232530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000232533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000232564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000232613.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000232656.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000232684.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000232686.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000232712.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000232725.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000232729.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232759.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000232788.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000232860.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000232876.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000232878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000232912.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000232913.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000232931.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000232934.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000232936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000233008.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000233008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000233029.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000233061.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000233117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000233137.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000233137.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000233184.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000233191.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000233223.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233237.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000233242.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000233242.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000233242.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000233330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000233368.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000233427.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000233483.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000233559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000233559.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233590.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000233627.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000233651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000233654.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000233725.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000233775.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000233783.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000233817.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000233825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000233852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000233893.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000233912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000233912.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000234019.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000234028.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000234072.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000234084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234139.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000234141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000234183.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000234199.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234210.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000234232.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000234252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234264.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000234290.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234290.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000234318.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000234393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000234437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000234445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234449.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000234492.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000234492.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000234571.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000234584.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000234584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000234665.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000234665.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234678.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000234684.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000234694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000234707.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000234753.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000234753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000234789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000234818.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000234818.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234899.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000234936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000234936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000234945.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234978.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234996.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000234997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000235007.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000235010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000235066.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000235072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000235072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000235117.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000235138.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000235159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000235192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000235277.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000235296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000235313.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000235326.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000235358.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000235387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000235398.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000235399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000235481.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000235488.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000235526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000235527.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000235560.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000235593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000235724.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000235760.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000235770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000235772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000235806.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000235820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000235823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000235831.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000235831.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000235843.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000235908.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000235910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000235927.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000236008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236051.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000236066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236088.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000236098.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000236199.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000236234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236266.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000236305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000236333.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000236345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000236345.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000236384.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000236388.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000236426.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000236434.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236434.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000236438.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000236494.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000236526.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000236540.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000236545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000236559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000236618.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000236643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236643.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000236658.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000236753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000236824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236830.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000236838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236901.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000236935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000236947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000236991.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000237017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000237021.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237036.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000237181.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000237184.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000237187.4 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000237234.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237248.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000237291.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000237298.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000237424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000237429.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000237438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237438.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000237457.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237485.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000237505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000237513.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000237520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000237596.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000237646.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000237689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000237697.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000237721.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000237742.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000237807.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000237886.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000237892.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000237899.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000237903.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000237927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000238005.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000238018.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000238058.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000238113.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000238140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000238164.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000238184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000238186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000238198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000238224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000238260.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000238266.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000238280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000239335.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000239445.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000239508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000239653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000239664.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000239911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000239930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000239994.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000240005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000240006.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000240050.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000240198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000240207.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000240211.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000240254.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000240449.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000240541.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000240541.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000240549.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000240549.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000240553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000240591.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000240859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000240922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000240990.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000240990.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000241014.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000241155.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000241280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000241280.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000241288.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000241481.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000241520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000241732.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000241732.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000241860.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000241884.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000241985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000242078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000242078.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000242125.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000242349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000242569.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000242578.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000242622.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000242628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000242767.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000242798.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000242908.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000242973.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000243055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000243176.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000243224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000243319.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000243479.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000243533.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000243715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000243766.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000244055.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000244124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000244198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000244215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000244268.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000244268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000244286.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000244300.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000244332.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000244345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000244380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000244393.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000244459.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000244558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000244558.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000244676.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000244676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000244791.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000245059.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000245060.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000245148.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000245330.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000245571.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000245711.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000245748.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000245849.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000245857.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000245937.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000246067.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000246130.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000246323.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000246331.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000246363.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000246379.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000246422.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000246523.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000246560.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000246731.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000246731.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000246777.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000246877.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000246898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000247095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000247095.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000247157.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000247199.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000247363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000247381.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000247556.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000247675.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000247679.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000247765.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000247853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000247853.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000247925.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000247970.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000248115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248175.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000248206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000248240.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000248243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000248243.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000248309.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000248323.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000248416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248544.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000248559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000248693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000248734.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000248774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000248787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000248787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000248846.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000248890.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000248896.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000248925.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000248925.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000248932.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000249084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000249207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000249216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000249234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000249249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000249258.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000249383.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000249407.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000249417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000249456.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000249464.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000249492.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000249509.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000249595.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000249599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000249602.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000249635.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000249655.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000249664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000249807.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000249849.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000249867.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000249868.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000249993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000250015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000250057.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000250061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250069.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000250122.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000250170.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000250267.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000250295.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000250302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000250410.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000250451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000250546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000250616.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000250786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250786.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000250802.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000250893.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000250900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250900.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000250903.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000250909.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000250950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000251003.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000251018.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000251034.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000251131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000251175.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000251194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000251221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000251364.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000251365.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000251381.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000251405.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000251417.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000251432.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000251442.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000251497.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000251513.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000251526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000251532.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000251580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000251603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000251661.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000251675.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000253112.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253174.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000253197.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000253263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000253301.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253307.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000253315.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000253392.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000253399.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000253404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000253405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000253477.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253552.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000253553.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000253576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000253603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000253632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253636.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000253641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000253642.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000253653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000253669.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000253678.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253696.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000253716.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000253764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000253824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253829.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000253829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253865.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000253898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000253948.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253961.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253961.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000253961.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000253965.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000253968.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000254034.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254109.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254162.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000254180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000254204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000254204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254231.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000254238.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000254263.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000254267.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000254347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000254444.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000254444.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000254461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000254461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254473.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000254526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000254532.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000254538.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254539.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000254577.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000254664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000254671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000254688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000254814.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254839.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000254860.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000254885.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000254900.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000254990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000255029.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000255052.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000255089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255089.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255094.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000255100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255145.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000255148.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255158.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000255234.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000255236.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000255237.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000255237.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000255240.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000255241.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000255269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255276.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000255310.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000255327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255421.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000255487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000255495.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000255503.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000255509.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000255539.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255670.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255741.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000255847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000255856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000255886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000255893.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000255970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000255970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000255989.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000256008.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000256008.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000256031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000256092.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000256116.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000256124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000256299.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000256325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000256377.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000256381.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000256452.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000256542.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000256546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000256588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000256603.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000256670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000256742.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000256746.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000256751.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000256789.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000256943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000257027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000257027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000257052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000257095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257114.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257151.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000257176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000257256.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000257261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000257264.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000257283.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000257381.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000257391.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000257391.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000257475.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000257496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000257534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000257563.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000257568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257595.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000257613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257696.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000257696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000257702.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000257748.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000257831.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000257859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000257910.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000257910.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000257913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000257999.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000258001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000258044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258048.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000258048.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000258057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000258096.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000258099.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000258101.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000258102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000258325.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258355.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000258410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000258443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000258457.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000258458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258458.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000258461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000258479.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000258486.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000258526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258620.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000258623.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000258682.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000258689.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000258704.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000258725.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000258731.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000258766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258809.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258811.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000258811.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000258813.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000258959.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259001.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000259002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000259062.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000259103.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000259163.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259182.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259206.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259225.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259238.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000259242.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259274.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000259294.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259319.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000259322.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000259327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000259343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259362.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259376.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000259396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259398.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000259473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259595.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000259595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259618.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000259705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259709.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259758.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000259758.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000259758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259760.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000259772.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000259792.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000259793.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000259804.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000259806.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000259843.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000259876.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000259876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259877.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000259883.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000259888.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000259915.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000259935.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000259954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260006.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260088.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000260118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260132.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000260136.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260167.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260176.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260186.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260196.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260213.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000260261.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260273.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000260273.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000260276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260277.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260281.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000260285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000260317.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260329.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260336.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000260349.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260351.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000260381.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260400.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000260409.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260417.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000260436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000260440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260448.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260464.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260464.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000260466.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000260467.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260484.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000260493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260534.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000260545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260565.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000260572.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000260604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260616.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000260635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000260651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000260698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260708.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260735.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260735.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260742.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000260805.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000260833.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000260837.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000260855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000260855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000260871.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000260874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000260891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000260898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000260948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000260949.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000260955.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000260988.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261002.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261003.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261040.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261064.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261114.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261131.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000261131.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000261140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261173.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261186.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000261186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261189.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261195.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261238.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000261253.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000261266.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261267.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261291.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261291.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261326.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261337.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261366.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261392.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261431.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000261433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261437.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000261437.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000261451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000261474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000261512.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261529.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261572.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000261574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261592.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000261596.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000261644.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000261731.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000261731.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261760.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000261773.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000261775.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000261777.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000261799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000261804.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000261824.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000261838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000261889.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000261916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000261996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000262089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000262147.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000262172.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000262185.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000262185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262313.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000262319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000262468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000262482.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000262482.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000262558.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000262580.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000262619.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000262668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000262721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262810.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000262810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000262903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262921.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000262944.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000262966.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000263004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263050.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000263063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000263063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000263105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000263105.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000263120.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263220.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263257.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263272.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000263280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263293.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000263293.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000263338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263370.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263400.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000263470.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000263624.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263680.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000263727.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000263727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263753.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000263847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000263859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000263893.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000263934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000264026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000264125.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000264167.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000264188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000264196.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000264290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000264456.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000264491.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000264513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000264520.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000264548.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000264575.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000264575.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000264608.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000264672.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000264729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000264860.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000264860.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000264932.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000264937.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000264954.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000265008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000265010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000265091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000265091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000265185.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000265204.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000265443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000265496.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000265666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000265728.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000265750.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000265787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000265908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000265912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000265984.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000266236.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000266256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000266256.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000266278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266304.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000266312.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000266312.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000266313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000266456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000266473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000266554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266573.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266601.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000266654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000266667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000266677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000266717.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000266783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000266783.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000266805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000266821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000266821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000266850.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000266913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000266969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000266970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000266970.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000266976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000266994.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000266999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000267009.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267009.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000267015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267016.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267042.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000267108.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000267117.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000267117.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267118.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267147.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000267272.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267273.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267284.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000267288.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267288.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000267289.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267296.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000267302.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000267308.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000267316.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000267373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267388.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000267390.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000267419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267475.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267491.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000267498.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267546.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267666.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000267667.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000267667.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000267701.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000267702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000267709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000267715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000267715.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000267734.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000267747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000267758.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000267778.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000267852.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000267852.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000267905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000267919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267924.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000267927.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000267939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000267940.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000268006.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000268027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000268051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000268081.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000268189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000268307.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000268307.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000268307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000268362.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000268458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000268471.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000268518.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000268520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000268573.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000268583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000268584.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000268613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000268621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000268650.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000268650.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000268655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000268751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000269044.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269082.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000269202.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000269290.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000269397.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000269439.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000269444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000269481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000269688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000269707.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000269887.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000269898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000269910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000269921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000269924.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000269940.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269940.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000269947.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269947.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000269951.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269958.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269958.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000269959.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000269973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000269974.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000270000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000270000.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000270001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000270006.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270028.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270031.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000270039.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000270062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270066.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000270074.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000270074.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000270081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000270083.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270102.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000270103.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000270105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000270127.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000270130.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000270140.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270145.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000270157.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000270170.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000270184.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270246.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000270344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000270419.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000270419.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000270462.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000270589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000270604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000270607.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000270640.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000270673.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000270720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000270742.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000270751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000270828.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000270996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000270996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271119.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000271133.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000271185.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000271218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271228.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271259.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000271382.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000271398.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000271417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271533.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271554.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000271631.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271659.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000271732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000271755.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271757.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271762.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000271781.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271781.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000271782.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000271788.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000271789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000271803.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000271821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271821.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000271826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000271826.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000271833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000271835.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000271843.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271849.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271851.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000271851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000271856.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271888.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000271888.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000271912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000271926.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000271943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000271993.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272003.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272023.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000272033.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272040.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272043.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272070.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272072.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272077.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000272079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272109.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272148.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272156.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272158.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000272192.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000272198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272205.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000272209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272225.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272250.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272250.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272273.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000272275.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000272346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272361.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-562271 |
ENSG00000272369.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272403.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000272444.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272463.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272473.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272512.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272518.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272518.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272520.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000272554.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000272556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272562.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272609.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272659.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272659.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272660.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-562271 |
ENSG00000272696.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000272760.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272764.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272787.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272828.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272858.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272866.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000272872.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272885.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000272888.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000272895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272902.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272904.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000272904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000272904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000272917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000272922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000272949.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272966.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000272970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000272977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000272983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000272983.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000272993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000273007.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273076.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-562271 |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-562271 |
ENSG00000273145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000273174.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000273203.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273203.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000273209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273232.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000273240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000273253.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-562271 |
ENSG00000273270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000273302.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-562271 |
ENSG00000273343.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000273353.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-562271 |
ENSG00000273367.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000273381.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-562271 |
ENSG00000273402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-562271 |
ENSG00000273407.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000273416.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-562271 |
ENSG00000273424.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-562271 |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-562271 |
ENSG00000273447.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| PF-562271 |
ENSG00000273456.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-562271 |
ENSG00000273471.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| PF-562271 |
ENSG00000273474.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
